Drug Shortage Report for ETOPOSIDE INJECTION USP
Report ID | 33330 |
Drug Identification Number | 02380935 |
Brand name | ETOPOSIDE INJECTION USP |
Common or Proper name | ETOPOSIDE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ETOPOSIDE |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 25ML VIAL |
ATC code | L01CB |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-12-22 |
Actual start date | 2017-12-18 |
Estimated end date | 2018-01-29 |
Actual end date | 2018-01-26 |
Shortage status | Resolved |
Updated date | 2018-01-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-12-15 | English | Compare |
v2 | 2017-12-15 | French | Compare |
v3 | 2017-12-23 | English | Compare |
v4 | 2018-01-08 | English | Compare |
v5 | 2018-01-08 | French | Compare |
v6 | 2018-01-29 | English | Compare |
v7 | 2018-01-29 | French | Compare |
Showing 1 to 7 of 7